| Financial Year |
March 31 2023 |
| Monetary Funds |
1,728,131,030.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,785,603,290.77 |
| Advances to Suppliers |
768,920,762.68 |
| Other Receivables |
467,932,013.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
289,855,601.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
248,425,161.56 |
| Total Current Assets |
5,591,687,414.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
175,346,579.32 |
| Long-term Equity Investment |
243,086,635.03 |
| Investment Properties |
-- |
| Fixed Assetes |
9,523,859,974.58 |
| Under-construction Projects |
2,187,367,740.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
816,561,671.70 |
| R&D expenses |
-- |
| Goodwill |
1,921,210.39 |
| Long-Term Deferred and Prepaid Expenses |
69,186,758.76 |
| Deferred Income Tax Assets |
2,851,817.55 |
| Other Non-Current Assets |
912,850,317.13 |
| Sub-Total of Non-Current Assets |
15,295,494,336.20 |
| Total Assets |
20,887,181,751.02 |
| Short-Term Loans |
3,457,232,194.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,283,162,311.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,697,464.74 |
| Taxes Payable |
58,553,211.20 |
| Interest Payable |
-- |
| Dividend Payable |
55,522.50 |
| Other payables |
692,480,473.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,863,221,700.47 |
| Other Current Liabilities |
506,438,856.23 |
| Sub-Total of Current Liabilities |
8,896,528,487.55 |
| Long-term Loans |
9,674,161,715.83 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
500,258,510.02 |
| Special Payable |
-- |
| Estimatied Liabilities |
24,736,189.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,561,061,980.07 |
| Total Liabilities |
19,457,590,467.62 |
| Paid-In Capital(Or Share Stock) |
2,031,124,274.00 |
| Capital Surplus |
5,203,811,216.98 |
| Surplus Reserve |
74,109,049.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-6,034,367,444.29 |
| Minority Stockholder's Interest |
132,129,886.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,297,461,397.01 |
| Owner's Equity（Stockholder's Equity） |
1,429,591,283.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,887,181,751.02 |
